Medigene AG MDGEF:OTCPK

RT Quote | Exchange | USD
Last | 04/22/22 EDT
3.21UNCH (UNCH)
52 week range
2.58 - 5.15
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close3.21
  • 52 Week High5.15
  • 52 Week High Date06/10/21
  • 52 Week Low2.58
  • 52 Week Low Date01/24/22

Key Stats

  • Market Cap68.22M
  • Shares Out24.56M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close3.21
  • 52 Week High5.15
  • 52 Week High Date06/10/21
  • 52 Week Low2.58
  • 52 Week Low Date01/24/22
  • Market Cap68.22M
  • Shares Out24.56M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.47
  • P/E (TTM)-6.89
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/10/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Medigene AG

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Medigene AG is a Germany-based biotechnology company that develops treatment platforms to target various types and stages of cancer with candidates in clinical and pre-clinical development. The Company focuses on the development of personalized T cell-based immunotherapies. It develops three platforms: T-cell receptor (TCR)-modified T cells for adoptive T-cell therapy as treatments for patients with tumor burdens; Dendritic cell (DC) vaccines for the treatment of low tumor...
Axelsven Malkomes
Chief Financial Officer, Chief Business Development Officer, Member of the Management Board
Address
Lochhamer Strasse 11
Planegg
82152
Germany